A carregar...

Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer

BACKGROUND: Approximately 80% of breast cancers amongst premenopausal women are hormone receptor‐positive. Adjuvant endocrine therapy is an integral component of care for hormone receptor‐positive breast cancer and in premenopausal women includes oestrogen receptor blockade with tamoxifen, temporary...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Bui, Kim Tam, Willson, Melina L, Goel, Shom, Beith, Jane, Goodwin, Annabel
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2020
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059882/
https://ncbi.nlm.nih.gov/pubmed/32141074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013538
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!